SOMAXON PHARMACEUTICALS, INC. Interest Expense
SOMAXON PHARMACEUTICALS, INC. reported Interest Expense of $1.94 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. interest expense for the quarter ending 2011-12-31 was $15.00K, a 72.73% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. interest expense for the quarter ending 2011-09-30 was $1.93M.
- SOMAXON PHARMACEUTICALS, INC. interest expense for the quarter ending 2010-12-31 was $55.00K.
- SOMAXON PHARMACEUTICALS, INC. interest expense for fiscal 2011 was $1.94M, a 2752.94% increase from fiscal 2010.
- SOMAXON PHARMACEUTICALS, INC. interest expense for fiscal 2010 was $68.00K, a 73.95% decline from fiscal 2009.
- SOMAXON PHARMACEUTICALS, INC. interest expense for fiscal 2009 was $261.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $1.94M derived: sum of 2 quarters · filed 2012-11-01 | $1.94M 10-K · filed 2012-03-09 | |
| 2011-09-30 | $1.93M 10-Q · filed 2012-11-01 | $1.93M 10-Q · filed 2012-11-01 | ||
| 2010-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $68.00K 10-K · filed 2012-03-09 | ||
| 2010-09-30 | $13.00K 10-Q · filed 2011-11-04 | |||
| 2009-12-31 | $261.00K 10-K · filed 2012-03-09 |